BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9834232)

  • 1. Modulation of granulocyte-macrophage colony-stimulating factor gene expression by a tumor necrosis factor specific ribozyme in juvenile myelomonocytic leukemic cells.
    Iversen PO; Sioud M
    Blood; 1998 Dec; 92(11):4263-8. PubMed ID: 9834232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of proliferation and induction of apoptosis in juvenile myelomonocytic leukemic cells by the granulocyte-macrophage colony-stimulating factor analogue E21R.
    Iversen PO; Rodwell RL; Pitcher L; Taylor KM; Lopez AF
    Blood; 1996 Oct; 88(7):2634-9. PubMed ID: 8839857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deoxyribonucleic acid triplex formation inhibits granulocyte macrophage colony-stimulating factor gene expression and suppresses growth in juvenile myelomonocytic leukemic cells.
    Kochetkova M; Iversen PO; Lopez AF; Shannon MF
    J Clin Invest; 1997 Jun; 99(12):3000-8. PubMed ID: 9185524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor is toxic to blasts from patients with juvenile myelomonocytic leukemia and chronic myelomonocytic leukemia.
    Frankel AE; Lilly M; Kreitman R; Hogge D; Beran M; Freedman MH; Emanuel PD; McLain C; Hall P; Tagge E; Berger M; Eaves C
    Blood; 1998 Dec; 92(11):4279-86. PubMed ID: 9834234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Raf-1 gene expression by a DNA enzyme inhibits juvenile myelomonocytic leukemia cell growth.
    Iversen PO; Emanuel PD; Sioud M
    Blood; 2002 Jun; 99(11):4147-53. PubMed ID: 12010819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of granulocyte-macrophage colony-stimulating factor prevents dissemination and induces remission of juvenile myelomonocytic leukemia in engrafted immunodeficient mice.
    Iversen PO; Lewis ID; Turczynowicz S; Hasle H; Niemeyer C; Schmiegelow K; Bastiras S; Biondi A; Hughes TP; Lopez AF
    Blood; 1997 Dec; 90(12):4910-7. PubMed ID: 9389708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional NF-IL6/CCAAT enhancer-binding protein is required for tumor necrosis factor alpha-inducible expression of the granulocyte colony-stimulating factor (CSF), but not the granulocyte/macrophage CSF or interleukin 6 gene in human fibroblasts.
    Kiehntopf M; Herrmann F; Brach MA
    J Exp Med; 1995 Feb; 181(2):793-8. PubMed ID: 7530764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central role of tumour necrosis factor, GM-CSF, and interleukin 1 in the pathogenesis of juvenile chronic myelogenous leukaemia.
    Freedman MH; Cohen A; Grunberger T; Bunin N; Luddy RE; Saunders EF; Shahidi N; Lau A; Estrov Z
    Br J Haematol; 1992 Jan; 80(1):40-8. PubMed ID: 1311195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of interleukin-1 and tumor necrosis factor-alpha induced granulocyte-macrophage colony-stimulating factor gene expression: potential involvement of arachidonic acid metabolism.
    Rizzo MT; Boswell HS
    Exp Hematol; 1994 Jan; 22(1):87-94. PubMed ID: 8282065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RAS-blocking bisphosphonate zoledronic acid inhibits the abnormal proliferation and differentiation of juvenile myelomonocytic leukemia cells in vitro.
    Ohtsuka Y; Manabe A; Kawasaki H; Hasegawa D; Zaike Y; Watanabe S; Tanizawa T; Nakahata T; Tsuji K
    Blood; 2005 Nov; 106(9):3134-41. PubMed ID: 16046524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte-macrophage colony-stimulating factor expression is regulated at transcriptional and posttranscriptional levels in a murine bone marrow stromal cell line.
    Derigs HG; Reifel-Miller A; Kaushansky K; Hromas RA; Boswell HS
    Exp Hematol; 1994 Aug; 22(9):924-32. PubMed ID: 8062890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of interferon-alpha (IFN) on the expression of interleukin 1-beta (IL-1), interleukin 6 (IL-6), granulocyte-macrophage colony-stimulating factor (GM-CSF) and tumor necrosis factor-alpha (TNF) in acute myeloid leukemia (AML) blasts.
    Sissolak G; Hoffbrand AV; Mehta AB; Ganeshaguru K
    Leukemia; 1992 Nov; 6(11):1155-60. PubMed ID: 1434798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of juvenile myelomonocytic leukemia cell growth in vitro by farnesyltransferase inhibitors.
    Emanuel PD; Snyder RC; Wiley T; Gopurala B; Castleberry RP
    Blood; 2000 Jan; 95(2):639-45. PubMed ID: 10627474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-1 alpha also induces granulocyte-macrophage colony-stimulating factor in immature normal bone marrow cells.
    Bot FJ; Schipper P; Broeders L; Delwel R; Kaushansky K; Löwenberg B
    Blood; 1990 Jul; 76(2):307-11. PubMed ID: 1695108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autocrine transformation of human hematopoietic cells after transfection with an activated granulocyte/macrophage colony stimulating factor gene.
    Hoyle PE; Steelman LS; McCubrey JA
    Cytokines Cell Mol Ther; 1997 Sep; 3(3):159-68. PubMed ID: 9426974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor regulates the expression of granulocyte-macrophage colony-stimulating factor and interleukin-3 receptors on human acute myeloid leukemia cells.
    Elbaz O; Budel LM; Hoogerbrugge H; Touw IP; Delwel R; Mahmoud LA; Löwenberg B
    Blood; 1991 Mar; 77(5):989-95. PubMed ID: 1825289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human somatic PTPN11 mutations induce hematopoietic-cell hypersensitivity to granulocyte-macrophage colony-stimulating factor.
    Chan RJ; Leedy MB; Munugalavadla V; Voorhorst CS; Li Y; Yu M; Kapur R
    Blood; 2005 May; 105(9):3737-42. PubMed ID: 15644411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemopoietin-1 activity of interleukin-1 (IL-1) on acute myeloid leukemia colony-forming cells (AML-CFU) in vitro: IL-1 induces production of tumor necrosis factor-alpha which synergizes with IL-3 or granulocyte-macrophage colony-stimulating factor.
    Delwel R; van Buitenen C; Salem M; Oosterom R; Touw I; Löwenberg B
    Leukemia; 1990 Aug; 4(8):557-60. PubMed ID: 2201834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine-specific activation of distinct mitogen-activated protein kinase subtype cascades in human neutrophils stimulated by granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and tumor necrosis factor-alpha.
    Suzuki K; Hino M; Hato F; Tatsumi N; Kitagawa S
    Blood; 1999 Jan; 93(1):341-9. PubMed ID: 9864179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth regulation of the AML-193 leukemic cell line: evidence for autocrine production of granulocyte-macrophage colony-stimulating factor (GM-CSF), and inhibition of GM-CSF-dependent cell proliferation by interleukin-1 (IL-1) and tumor necrosis factor (TNF alpha).
    Kindler V; Shields J; Ayer D; Mazzei GJ
    Int J Cancer; 1991 Feb; 47(3):450-4. PubMed ID: 1993554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.